In June 2019, MLP Ventures’ The Discovery Labs announced renovation plans for GlaxoSmithKline’s R&D space in King of Prussia, Pennsylvania it acquired the previous year for about $50 million with the goal of turning the space into “co-working” ecosystem for healthcare, life sciences and technology-enabled companies.
{iframe}https://www.biospace.com/article/the-discovery-labs-colony-in-pennsylvania-creates-environment-for-collaborative-partnerships/{/iframe}